FDA Orange Book · active-ingredient family
Amiloride hydrochloride
Amiloride hydrochloride is approved as 1 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:MIDAMOR · NDA 018200
1
Brand (NDA)
3
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| MIDAMORRLD | PADAGIS US | NDA 018200 | AB | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (3)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| AMILORIDE HYDROCHLORIDE | CHARTWELL RX | ANDA 204180 | — | Aug 07, 2015 | |
| AMILORIDE HYDROCHLORIDE | SIGMAPHARM LABS LLC | ANDA 079133 | AB | Jan 30, 2009 | |
| AMILORIDE HYDROCHLORIDE | PH HEALTH | ANDA 070346 | AB | Jan 22, 1986 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Amiloride hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

